By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Vertex is seeking a Senior Medical Science Liaison to act as a scientific liaison to the medical and academic community, building relationships with HCPs and shaping the medical plan. Heeft u wat nodig is om te
Revolution Medicines is seeking a Medical Science Liaison for the Netherlands to engage in peer-to-peer scientific dialogue with healthcare professionals and translate insights into internal actions. Dien uw cv en eventuele aanvullende vereiste informatie in nadat
Company Description Who we are? We are JDE Peet’s. We craft coffee for every cup and build brands for every heart. JDE Peet’s - now part of Keurig Dr Pepper – is the world’s leading pure-play
Job Description Zet nu de volgende stap in uw carrière. Scroll naar beneden om de volledige functieomschrijving te lezen en te solliciteren. General Summary: The Senior Medical Science Liaison (Sr MSL) will serve as a scientific liaison
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
If you feel like you’re part of something bigger, it’s because you are. At Amgen our shared mission—to serve patients—drives all that we do. It is key to becoming one of the world’s leading biotechnology companies.